Ben Taylor

Ben Taylor

Director of Finance/CFO at RECURSION PHARMACEUTICALS, INC.

Net worth: 4 M $ as of 30/06/2026

48 year
Health Technology
Finance
Technology Services

Profile

Ben R.
Taylor
is currently Chief Financial Officer & President-UK Region at Recursion Pharmaceuticals, Inc. since 2024.
Former roles include Chief Financial Officer & Executive Director at Exscientia AI Ltd. from 2020 to 2024; Chief Financial & Strategy Officer, Director at Exscientia Ltd.; Head-Emerging Pharm at Goldman Sachs & Co. LLC from 2012 to 2016; Head-Commercial Pharm at Barclays Capital, Inc. from 2016 to 2017; Chief Financial Officer at Aetion, Inc. in 2020; and President & Chief Financial Officer at Tyme Technologies, Inc. from 2017 to 2020.
Education includes undergraduate studies at Brown University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
15/06/2026 1,101,876 ( 0.21% ) 4 M $ 30/06/2026

Ben Taylor active positions

CompaniesPositionStart
RECURSION PHARMACEUTICALS, INC. Director of Finance/CFO 20/11/2024

Former positions of Ben Taylor

CompaniesPositionEnd
Director of Finance/CFO 01/11/2024
Director of Finance/CFO 01/11/2020
TYME TECHNOLOGIES, INC. Director of Finance/CFO 01/08/2020
Corporate Officer/Principal 01/01/2017
Corporate Officer/Principal 01/02/2016
See the detail of Ben Taylor's experience

Training of Ben Taylor

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

97

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Consumer Services

Finance

Finance

Technology Services

Health Technology

Technology Services